Man Lives Without Lungs: Groundbreaking Transplant Success Story
The fundamental principle of human physiology dictates that life cannot exist without functioning lungs. Yet, a medical team in the United States temporarily defied this biological certainty. For 48 hours, a 33-year-old man survived completely without lungs, sustained by an artificial system while awaiting a bilateral transplant. Described in the January 29th issue of Med, published by the Cell Press group, the procedure—led by Ankit Bharat, a thoracic surgeon at Northwestern University in Chicago—represents a potential breakthrough in treating the most severe cases of acute respiratory failure.
A Patient at the Brink
In the spring of 2023, the young man, a resident of Missouri, was urgently admitted to the Northwestern Memorial Hospital. He required extracorporeal membrane oxygenation (ECMO), a life-support technique that assists heart and lung function in patients with severe, acute failure unresponsive to conventional treatments. “He was gravely ill. His heart stopped as soon as he arrived. We had to resuscitate him,” recounts Bharat. He was diagnosed with acute respiratory distress syndrome (ARDS), a potentially fatal condition—widely recognized during the Covid-19 pandemic—characterized by fluid leakage from pulmonary capillaries into the air sacs of the lungs. Triggered by influenza and complicated by bacterial pneumonia, the illness rapidly compromised his heart and kidneys. “When the infection is so severe that the lungs are dissolving, they are irreversibly damaged. That’s when patients die,” explains the surgeon.
Removing the Lungs to Save a Life
The only chance of survival was a double lung transplant. However, the infected lungs continued to fuel sepsis, and the patient’s body was too unstable to accept new organs. “Heart and lungs are intrinsically connected,” observes Bharat. “When there are no lungs, how do you keep the patient alive?” The answer was radical: completely remove the lungs and temporarily replace their functions with an artificial system capable of oxygenating the blood, eliminating carbon dioxide, and maintaining adequate blood flow. This complex technology allowed the body to “rest” and recover.
A Bridge to Transplant
Following the removal of the lungs, the patient’s condition improved: blood pressure stabilized, organ function recovered, and the infection subsided. Two days later, donor lungs became available, and the team performed the bilateral transplant. More than two years later, the man is living a normal life and breathing well. Molecular analysis of the removed lungs revealed widespread scarring and irreversible immune damage. “For the first time, biologically, we are providing molecular proof that some patients will need a double lung transplant, otherwise they will not survive,” Bharat states.
Italian Experience and the Lesson of Covid
This approach builds on prior experience. As noted by Professor Mario Nosotti, director of the Thoracic Surgery and Lung Transplant Complex Structure at the Irccs Policlinico di Milano, and a leading Italian expert in the field, “I know Ankit Bharat well. In collaboration with colleagues in Vienna and Florida, we published the first lung transplants in patients with COVID-19 on Lancet.” At the time, it was “a real leap of faith,” because “acute and devastating lung infection had always been considered an absolute contraindication to transplantation.” These experiences demonstrated that “it was possible to take risks and achieve good results.” According to Nosotti, the Chicago intervention is logically sound: “If the lungs are infected and dragging the entire organism into the abyss, let’s remove them, let the organism recover, and then replace them with a transplant.”
Cautious Optimism and Defining Indications
The technology, Nosotti emphasizes, “exists and has been consolidated for years”: extracorporeal circulation supports “hundreds, if not thousands, of patients” worldwide every day. The crucial point is different: “The problem is to give the right indication to the right patient. In other words, a pathology certainly limited to the lungs in a patient otherwise completely healthy.” Nosotti urges caution regarding claims about ARDS: “The great competence of our intensivists allows many patients to return to their normal lives after a dramatic event like ARDS.”
He also notes that transplantation involves immunosuppressive therapies and lifelong monitoring: “There is no doubt that breathing with your own lungs is better than with transplanted ones. We must not convey the message that from tomorrow all patients with ARDS should be transplanted.” The true novelty, he concludes, “lies not so much in keeping a patient alive for a few days without lungs, but in the concept of removing the site of infection, allowing the organism to recover, and then performing the transplant.” This is a conceptual, rather than technical, frontier that opens new possibilities but requires rigorous criteria and great responsibility.
Frequently Asked Questions
What was the primary reason for removing the patient’s lungs?
The patient’s lungs were severely infected and causing sepsis, making his body too unstable to receive a transplant while the lungs remained in place.
How long did the patient survive without lungs?
The patient survived for 48 hours without lungs, sustained by an artificial system, while awaiting a bilateral transplant.
What is ARDS, and why is it so dangerous?
ARDS, or acute respiratory distress syndrome, is a potentially fatal condition where fluid leaks into the lungs, impairing oxygen exchange. It became widely known during the Covid-19 pandemic and can lead to irreversible lung damage.
Given the complexities and potential benefits of this innovative approach, what further research is needed to determine which patients might benefit most from this type of intervention?